fda warning compounded semaglutide october 2025 Beyond the Headlines: Letters to GLP-1 Compounders Semaglutide shortage ends as FDA

These aggregated substances may increase the risk of formulation instability and potential sensitization

Policy 16, 645657

CagriSema: Doubling Down CagriSema is a combination drug that pairs semaglutide (the ingredient in Ozempic) with another hormone called amylin

On sale now, and they sell out fast, so dont sit on it

They also provide additional health benefits: Lower blood sugar levels (beneficial for diabetes and prediabetes) Reduced cardiovascular risk (lower cholesterol and blood pressure) Protection against fatty liver disease Improved Compliance and Quality of Life Many individuals discontinue older medications due to side effects, ineffectiveness, or safety concerns

Join the thousands who've succeeded with Henry Meds I dont constantly stress about what to eat